vTv Therapeutics (VTVT) Return on Sales (2016 - 2025)
Historic Return on Sales for vTv Therapeutics (VTVT) over the last 12 years, with Q3 2025 value amounting to 1669.35%.
- vTv Therapeutics' Return on Sales fell 16466400.0% to 1669.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 1669.35%, marking a year-over-year decrease of 16466400.0%. This contributed to the annual value of 22.33% for FY2024, which is N/A changed from last year.
- Per vTv Therapeutics' latest filing, its Return on Sales stood at 1669.35% for Q3 2025, which was down 16466400.0% from 1404.35% recorded in Q2 2025.
- In the past 5 years, vTv Therapeutics' Return on Sales ranged from a high of 0.49% in Q3 2021 and a low of 3068.33% during Q3 2023
- Moreover, its 5-year median value for Return on Sales was 357.78% (2022), whereas its average is 779.18%.
- Per our database at Business Quant, vTv Therapeutics' Return on Sales tumbled by -30542300bps in 2023 and then surged by 30456200bps in 2024.
- vTv Therapeutics' Return on Sales (Quarter) stood at 1053.67% in 2021, then surged by 36bps to 676.67% in 2022, then plummeted by -353bps to 3068.33% in 2023, then surged by 91bps to 261.0% in 2024, then crashed by -540bps to 1669.35% in 2025.
- Its last three reported values are 1669.35% in Q3 2025, 1404.35% for Q2 2025, and 1347.24% during Q1 2025.